Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KYMR)

Q: What does CUSIP 501575104 represent in this 13F holders report?

CUSIP 501575104 is the security identifier for KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q2 2026?

5 institutional investors reported KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 501575104

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, $0.0001 par value per share
Total 13F shares: 25,261
Total 13F value: $2,897,011
Share change: +487
SEC-reported price per share: $114.67
Number of holders: 5
Value change: +$59,089
Number of buys: 3
Number of sells: 3
Shares outstanding: 83,129,381

Security key

501575104

Report period

Q2 2026

Institutions

Top holders

KYMR full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Kymera Therapeutics, Inc. SEC filings Kymera Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 501575104

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

BAKER BROS. ADVISORS LP

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 13F 3/4/5 Lead comparable stake: 14% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Comparable ownership Top 5

FMR LLC 14%

BAKER BROS. ADVISORS LP 11%

PRICE T ROWE ASSOCIATES INC /MD/ 7.1%

T. Rowe Price Investment Manageme... 6.7%

BIOTECHNOLOGY VALUE FUND L P 6.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13D/G 13F Company 13D/G 13F	14%	$1,034,158,808 11,681,450 shares	+$243,712,112	31 Mar 2026
BAKER BROS. ADVISORS LP	3/4/5 13D/G 13F Director, 10%+ Owner · Company 3/4/5 13D/G 13F	11% from 13D/G	$1,134,150,081 18,187,946 shares mixed-class rows	+$172,499,918	24 Jun 2026
PRICE T ROWE ASSOCIATES INC /MD/	13F 13D/G Company · T. Rowe Price Associates, Inc. 13F 13D/G	7.1% from 13D/G	$504,809,000 6,060,847 shares	—	31 Mar 2026
T. Rowe Price Investment Management, Inc.	13D/G 13F Company 13D/G 13F	6.7%	$483,396,552 5,460,257 shares	$0	31 Mar 2026
BIOTECHNOLOGY VALUE FUND L P	13D/G 3/4/5 BVF PARTNERS L P/IL · Director, Other* 13D/G 3/4/5	6.3%	$427,875,237 5,237,151 shares	-$133,224,759	26 Jun 2026
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	5.4% from 13D/G	$421,520,382 5,060,876 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

25,261

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

255

Q2 2026 holders

Holder diff

-250

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend